These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Chemotherapy of metastatic cancer of the bladder. Apropos of 50 patients treated with M-VAC].
    Author: Beuzeboc P, Dhote R, Thiounn N, Flam T, Zerbib M, Debré B, Pouillart P.
    Journal: Cancer Radiother; 1998 Apr; 2 Suppl 1():92s-96s. PubMed ID: 9749087.
    Abstract:
    The most effective chemotherapy of metastatic bladder cancer in M-VAC (methotrexate, vinblastine, cisplatin), as it was shown M-VAC by phase III trials. The complete remission rate is 15-20%. The toxicity is severe, and M-VAC cannot be delivered to fragile patients. Survival is improved. This increase in survival results in an increased incidence in brain metastases. The Cochin Hospital experience with 50 patients treated with M-VAC for a metastatic bladder cancer is presented.
    [Abstract] [Full Text] [Related] [New Search]